Rifapentine is a semisynthetic rifamycin antibiotic primarily used in the treatment of tuberculosis (TB). It exhibits potent activity against Mycobacterium tuberculosis by inhibiting bacterial DNA-dependent RNA polymerase, thus blocking RNA synthesis. Rifapentine has a longer half-life compared to rifampin, allowing for less frequent dosing and is often used in short-course regimens for latent or active TB, including in combination with isoniazid.
It is administered orally and is approved in several countries for both active TB treatment and latent TB infection (LTBI) therapy.
Therapeutic indications include:
• Treatment of active pulmonary tuberculosis
• Latent tuberculosis infection (LTBI) in combination therapy
• Part of short-course TB regimens with isoniazid and other agents
Parent: Rifapentine
Parent: Rifapentine / Rifampicin
Impurities in rifapentine primarily arise from its fermentation-derived precursor (rifamycin B) and subsequent semi-synthetic modification steps. Due to its macrocyclic structure, it is sensitive to light, pH, and oxidative degradation. Control of impurities is crucial, especially because rifapentine is used in long-term therapy.
Regulatory limits are defined under ICH Q3A/B and ICH Q3D, and USP/EP monographs for rifapentine drug substance and product.
Process-Related Impurities
• Rifampin, rifamycin S, or rifamycin B (synthetic precursors or incomplete conversions)
• Impurities from acylation reactions (e.g., 25-desacetyl rifapentine)
• Isomeric or epimeric forms (e.g., E/Z isomers of rifapentine)
• Residual solvents such as methanol, acetone, or pyridine
Degradation Impurities
• Hydrolysis products under acidic or basic conditions
• Oxidized forms (e.g., quinone-type degradation products)
• Desacetylated rifapentine (common major degradant)
• Photodegradation compounds due to macrocycle instability under light
Elemental Impurities
• Trace metals such as iron, zinc, or copper from fermentation or reactor vessels
• Controlled as per ICH Q3D for oral medications
Analytical Techniques for Impurity Detection
Rifapentine is used for treating active and latent tuberculosis, often in combination with other antimycobacterial drugs like isoniazid.
It inhibits bacterial RNA polymerase, blocking transcription and effectively killing Mycobacterium tuberculosis.
Rifapentine has a longer half-life, allowing for less frequent dosing, but choice depends on the TB regimen and patient factors.
Store below 25°C in a tightly closed container, protected from light and moisture to prevent degradation.
